"Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel." by Zhen Ning Wee

Selected Works of Dave S.B. Hoon, PhD

Follow Contact

Article

Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.

Nature Communications (2015)

Zhen Ning Wee
Siti Maryam J. M. Yatim
Vera K. Kohlabauer
Min Feng
Jian Yuan Goh
Yi Bao
Puay Leng Lee
Songjing Zhang
Pan Pan Wang
Elgene Lim
Wai Leong Tam
Yu Cai
Henrik J. Ditzel
Dave S. B. Hoon
Ern Yu Tan
Qiang Yu

Link

Disciplines

Biology,
Bioinformatics,
Molecular Biology and
Oncology

Publication Date

December 1, 2015

DOI

10.1038/ncomms10054

Citation Information

Zhen Ning Wee, Siti Maryam J. M. Yatim, Vera K. Kohlabauer, Min Feng, et al.. "Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel." Nature Communications Vol. 6 Iss. 1 (2015) p. 10054 - 10054
Available at: http://works.bepress.com/dave-hoon/67/